What are the typical liver stiffness cutoff values on FibroScan and how do they correlate with stages of hepatic fibrosis?

FibroScan Liver Stiffness Cutoff Values and Fibrosis Staging

For most chronic liver diseases, use a FibroScan cutoff of 12.5 kPa to detect cirrhosis, 10 kPa for advanced fibrosis (F3-4), and 7 kPa for significant fibrosis (F2-4), though these thresholds vary by etiology and should be interpreted with caution in the presence of active inflammation, obesity, or acute hepatic injury. 1

Universal Diagnostic Thresholds

The most recent guidelines establish clear stiffness thresholds across liver diseases:

• LSM >12 kPa provides >90% specificity for compensated advanced chronic liver disease (cACLD) and serves as the primary diagnostic threshold 1
• LSM >15 kPa is highly suggestive of cACLD/cirrhosis and should trigger evaluation for portal hypertensive complications 1
• LSM 20-25 kPa indicates clinically significant portal hypertension 1

Rule-Out Thresholds

• **LSM <8 kPa** in NAFLD or alcoholic liver disease yields >90% sensitivity for excluding cACLD 1
• **LSM <7 kPa** in chronic viral hepatitis provides >90% sensitivity for excluding cACLD 1

Etiology-Specific Cutoff Values

Chronic Hepatitis C

The 2025 AASLD systematic review provides the most comprehensive data:

• Significant fibrosis (F2-4): 7 kPa cutoff yields 75% sensitivity and 84% specificity 2
• Advanced fibrosis (F3-4): 10 kPa cutoff yields 87% sensitivity and 88% specificity 2
• Cirrhosis (F4): 13 kPa cutoff yields 88% sensitivity and 94% specificity 2

The 2017 AGA guideline recommends a 12.5 kPa cutoff for cirrhosis detection, deliberately accepting false-positives to minimize missing cirrhosis, particularly since post-SVR elastography often shows reduced stiffness values 3

Chronic Hepatitis B

• Significant fibrosis (F2-4): 7 kPa cutoff yields 78% sensitivity and 79% specificity 2
• Advanced fibrosis (F3-4): 8 kPa cutoff yields 87% sensitivity and 83% specificity 2
• Cirrhosis (F4): 11 kPa cutoff yields 81% sensitivity and 87% specificity 2, 1

The lower cirrhosis threshold (11 kPa vs. 12.5 kPa) accepts more false-positives because antiviral therapy often reduces stiffness and HCC surveillance is required regardless 1

NAFLD/MASLD

• Significant fibrosis (F2-4): 7 kPa cutoff yields 76% sensitivity and 73% specificity 2
• Advanced fibrosis (F3-4): 10 kPa cutoff yields 82% sensitivity and 79% specificity 2
• Cirrhosis (F4): 13 kPa cutoff yields 90% sensitivity and 89% specificity 2

Critical caveat: In high-risk NAFLD populations (older age, obesity, central adiposity, diabetes, markedly elevated ALT), magnetic resonance elastography outperforms transient elastography 1

Alcoholic Liver Disease

• Cirrhosis: 12.5 kPa cutoff achieves 95% sensitivity and 71% specificity 1
• Alternative data suggest 19.5 kPa for F4 with 85.7% sensitivity and 84.2% specificity 4

Critical Pitfalls and Confounders

Hepatic Inflammation

Active liver inflammation is the most important confounder that falsely elevates LSM values. 5

• Inflammation activity ≥2 (on histology) increases misdiagnosis risk 3.5-fold 5
• Elevated ALT/AST levels correlate with higher false-positive rates 5
• In chronic hepatitis B, acute flares can transiently raise LSM independent of fibrosis 5

Obesity and Metabolic Factors

• BMI ≥30 kg/m², waist circumference ≥102 cm, and increased parietal wall thickness markedly increase LSM failures and false-positive results 1, 6
• Using a generic >10 kPa cutoff in obese patients leads to substantial over-diagnosis 1
• Obesity-related factors increase technical failure rates for all elastography modalities 6

Other Confounders

• Acute hepatitis, cholestasis, and hepatic congestion transiently raise LSM values, potentially causing over-diagnosis 1
• Steatosis itself has minimal direct effect on LSM in multivariate analysis 6

Practical Implementation Algorithm

1. Perform two LSM assessments on separate days before confirming cACLD to improve diagnostic reliability 1

2. Check for confounders before interpretation:

   • Elevated ALT/AST (>2× ULN suggests active inflammation) 5
   • Recent alcohol consumption, acute illness, or right heart failure 1
   • BMI and waist circumference (consider MRE if BMI ≥30 in NAFLD) 1

3. Apply etiology-specific thresholds rather than universal cutoffs 2, 1

4. For post-SVR hepatitis C patients:

   • Use 9.5 kPa cutoff to rule out advanced fibrosis (F3-4) with 78% sensitivity 3
   • Repeat elastography after viral cure, as stiffness frequently decreases 3

5. Values <8 kPa reliably exclude advanced fibrosis across most etiologies, with 100% negative predictive value in post-transplant MASH patients 7

6. LSM ≥10 kPa predicts all-cause mortality independent of age and comorbidities in NAFLD (HR 2.31) 8